Algomedix Algomedix is a company engaged in the development of Transient Receptor Potential (TRP) therapeutics to treat serious medical needs, including chronic and acute pain. | ![]() CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. | ![]() NeurOp NeurOp is a biotechnology company developing medicines for the treatment of central nervous system (CNS) disorders including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression. | ![]() Acticor Biotech Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. | |
Founding Date | Founding Date 2010 | Founding Date 1992 | Founding Date 2002 | Founding Date 2013 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Mill Creek, US HQ | Locations Seattle, US HQ Köln, DE | Locations Atlanta, US HQ | Locations Paris, FR HQ Paris, FR |
Employees | Employees 1 | Employees 2546% decrease | Employees 6 | Employees 1711% decrease |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 155k (over 12 years ago) | Latest funding round $ 7.8m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 105m | Total funding raised N/A | Total funding raised $ 33.3m |

CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
View company
NeurOp is a biotechnology company developing medicines for the treatment of central nervous system (CNS) disorders including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression.
View company
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
View company